Rokos Capital Management LLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rokos Capital Management LLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,311,596
-21.5%
1,389,2960.0%0.32%
-41.1%
Q2 2023$56,474,882
+9.4%
1,389,2960.0%0.55%
-85.7%
Q1 2023$51,605,400
+81.8%
1,389,296
+68.2%
3.82%
+206.8%
Q4 2022$28,391,785
+69.8%
826,063
+184.3%
1.24%
+149.8%
Q3 2022$16,723,000
-0.7%
290,528
-12.6%
0.50%
+1.0%
Q2 2022$16,839,000
+108.3%
332,384
+198.1%
0.49%
+30.4%
Q1 2022$8,084,000111,5150.38%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders